Molina Healthcare, INC Form 4 insider transactions

Richard C. Zoretic, a Director at Molina Healthcare, Inc., was granted 237 shares of common stock on July 1, 2026, as part of his annual equity award.

Molina Healthcare reports a director, Richard M. Schapiro, received an equity award of 237 common stock shares valued at $55,000 on July 1, 2026.

Molina Healthcare, Inc. reports a stock grant to Director Ronna Romney under the company's equity incentive plan.

Steven J. Orlando, a Director at Molina Healthcare, Inc., was granted 237 shares of common stock valued at $55,000 as part of his annual equity award.

Molina Healthcare, Inc. reports a stock grant to Director Stephen H. Lockhart under the 2025 Equity Incentive Plan.

Molina Healthcare, Inc. reports a stock grant to Director Leo P. Grohowski under the 2025 Equity Incentive Plan.

Molina Healthcare, Inc. reports a stock grant to Director Francis S. Soistman Jr. under the 2025 Equity Incentive Plan.

Molina Healthcare, Inc. reports a director, Barbara L. Brasier, received a stock grant valued at $55,000 on July 1, 2026, as part of her annual equity award.

Molina Healthcare's Chief Operating Officer, James Woys, acquired company stock through the Employee Stock Purchase Plan on June 30, 2026.

Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, acquired company stock through an employee stock purchase plan.

Debra Bacon, EVP of Medicaid at Molina Healthcare, Inc., reported transactions involving the acquisition of common stock under an employee stock purchase plan and the disposition of shares for tax withholding.

Chief Accounting Officer Maurice Hebert sold 600 shares of Molina Healthcare common stock on May 14, 2026.

Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, reported the sale of 17,811 shares of common stock on May 11, 2026, for a total value of approximately $3.3 million.

Director Francis Soistman acquired 170 shares of Molina Healthcare common stock as part of a prorated quarterly director grant.

Molina Healthcare, Inc. reports a director, Leo P. Grohowski, received an equity award of 405 shares of common stock on April 1, 2026, valued at $135.82 per share.

Molina Healthcare, Inc. reports a director, Stephen H. Lockhart, received an equity award of 405 common shares valued at $135.82 per share on April 1, 2026.

Molina Healthcare, Inc. reports a director, Steven J. Orlando, received an equity award valued at $55,000 on April 1, 2026, as part of his annual compensation.

Molina Healthcare, Inc. reports a director, Dale B. Wolf, received an equity award valued at $55,000 on April 1, 2026, as part of his annual compensation.

Richard C. Zoretic, a Director at Molina Healthcare, Inc., received an equity award of 405 common shares valued at $135.82 per share on April 1, 2026, as part of his annual compensation.

Molina Healthcare reports a director's equity grant of 405 common shares on April 1, 2026, valued at $135.82 per share.

Molina Healthcare, Inc. reports a director, Barbara L. Brasier, received an equity award of 405 common stock shares on April 1, 2026, valued at $135.82 per share.

Molina Healthcare, Inc. reports a director, Ronna Romney, received an equity award of 405 shares valued at $135.82 per share on April 1, 2026, as part of her annual compensation.

Molina Healthcare director Ronna Romney reported the sale of 506 shares of common stock for approximately $146.92 per share, held indirectly by a trust, under a pre-arranged 10b5-1 plan.

Molina Healthcare's President and CEO, Joseph M. Zubretsky, reported the acquisition of 66,417 restricted shares and the disposition of 8,597 shares for tax withholding purposes.

Molina Healthcare's CFO, Mark Lowell Keim, increased his beneficial ownership by 26,073 shares through a restricted stock grant, despite a tax-related disposition.

Molina Healthcare's Chief Operating Officer, James Woys, reported the acquisition of 17,016 restricted shares and the disposition of 1,313 shares for tax withholding purposes.

Molina Healthcare's Chief Accounting Officer, Maurice Hebert, increased his direct beneficial ownership of common stock through performance unit settlements and restricted stock grants, partially offset by tax-related dispositions.

Molina Healthcare's Chief Legal Officer, Jeff D. Barlow, increased his beneficial ownership through a significant restricted stock grant, alongside a tax-related share disposition.

Molina Healthcare's EVP of Medicaid, Debra Bacon, reported the acquisition of 9,606 restricted common shares and the disposition of 716 shares for tax purposes.

Molina Healthcare Director Richard C. Zoretic acquired 800 shares of common stock at $125.16 per share, increasing his indirect beneficial ownership.